IP Verse

Boehringer Ingelheim Animal Health Usa Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Boehringer Ingelheim Animal Health Usa Inc.

Patent Number:
EP1957110
Title:
Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products Thereof
Applicant:
BAYER B.V.
Opposition Date:
Jun 22, 2021
Patent Number:
EP2819699
Title:
Controlled Release Compositions And Their Methods Of Use
Applicant:
BAYER NEW ZEALAND LIMITED
Opposition Date:
Feb 19, 2020
Patent Number:
EP2842569
Title:
One Dose Vaccination With Mycoplasma Hyopneumoniae
Applicant:
ZOETIS P LLC
Opposition Date:
Jan 3, 2020
Patent Number:
EP3041939
Title:
Recombinant Marek'S Disease Viruses And Uses Thereof
Applicant:
CEVA SANTE ANIMALE
Opposition Date:
Dec 24, 2019
Patent Number:
EP2598151
Title:
Compositions For Treating Heartworm Infestation
Applicant:
CEVA SANTÉ ANIMALE SA
Opposition Date:
Sep 25, 2019
Patent Number:
EP2803265
Title:
Spot-On Pesticide Composition
Applicant:
SERGEANT'S PET CARE PRODUCTS, INC.
Opposition Date:
Jul 22, 2019
Patent Number:
EP2768964
Title:
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Newcastle Disease Virus Antigens
Applicant:
INTERVET INTERNATIONAL B.V.
Opposition Date:
Jul 9, 2019
Patent Number:
EP2833910
Title:
Pcv/Mycoplasma Hyopneumoniae Combination Vaccine
Applicant:
ZOETIS LLC
Opposition Date:
Apr 4, 2019
Patent Number:
EP2833909
Title:
Pcv/Mycoplasma Hyopneumoniae/Prrs Combination Vaccine
Applicant:
ZOETIS LLC
Opposition Date:
Feb 7, 2019
Patent Number:
EP3185899
Title:
Improved Hvt-Vectored Nd-Ibd Vaccine
Applicant:
INTERVET INTERNATIONAL B.V.
Opposition Date:
Jul 16, 2018

Latest patents of Boehringer Ingelheim Animal Health Usa Inc. opposed by its competitors

Patent:
EP3035958
Grant Date:
Oct 26, 2022
Title:
Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine
Oppositions:
2
Patent:
EP3554536
Grant Date:
Oct 26, 2022
Title:
Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising Them
Oppositions:
1
Patent:
EP2785374
Grant Date:
Aug 17, 2022
Title:
Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof
Oppositions:
1
Patent:
EP2998315
Grant Date:
Nov 3, 2021
Title:
Newcastle Disease Virus Vectored Avian Vaccines
Oppositions:
1
Patent:
EP3061454
Grant Date:
Mar 10, 2021
Title:
Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof
Oppositions:
2
Patent:
EP2275132
Grant Date:
Mar 3, 2021
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them
Oppositions:
3
Patent:
EP3127551
Grant Date:
Jul 29, 2020
Title:
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
Oppositions:
3
Patent:
EP3320919
Grant Date:
May 27, 2020
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
2
Patent:
EP2460820
Grant Date:
Jun 19, 2019
Title:
Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Oppositions:
3
Patent:
EP2481420
Grant Date:
Feb 20, 2019
Title:
Single Dose Anti-Pcv2 Pig Vaccine
Oppositions:
2

Competitors of Boehringer Ingelheim Animal Health Usa Inc.

CEVA SANTE ANIMALE

INTERVET INTERNATIONAL B.V.

LABORATORIOS HIPRA, S.A.

Want to track Boehringer Ingelheim Animal Health Usa Inc.?

Feel free to send us a message here and we will get back to you